Research at Children's
About Us
Our Research
Faculty
By Research Center
By Name
Education
Clinical Trials
Latest News
Careers
 
 
Email this page Email This Page
Print this page Print This Page
 

  Join Us On:
  Follow Children's on Facebook  Facebook
  Follow Children's on Twitter  Twitter
  Watch Children's on YouTube  YouTube
 
 
     
 

Sasa Radoja, PhD
Children's National Medical Center
Principal Investigator, Children's Research Institute 
Center for Cancer and Immunology Research (CCIR)

George Washington University
School of Medicine and Health Sciences
Associate Professor, Pediatrics & Microbiology, Immunology, and Tropical Medicine

Contact Information
Children's National Medical Center
Center for Cancer and Immunology Research (CCIR)
111 Michigan Avenue, NW
Washington, DC 20010-2970

202-476-3537
sradoja@childrensnational.org

Education & Training
Institution & Location Degree Year(s) Field of Study
University of Belgrade, Yugoslavia BS 1993 Microbiology
University of Belgrade, Yugoslavia MS 1995 Molecular Biology
New York University School of Medicine, New York, NY PhD 2001 Immunology
Harvard Medical School, Boston, MA Post Doc. 2003 Molecular Biology

Research Interests
Sasa Radoja, PhD, is an expert in the field of cytotoxic lymphocytes (CTL) and is Associate Professor of Pediatrics and Microbiology, Immunology, and Tropical Medicine at GWU. Dr. Radoja graduated from the New York University School of Medicine in 2001, in the laboratory of Dr. Alan Frey where he used animal models to study T cell mediated tumor immunity. For the postdoctoral training he joined the laboratory of Dr. Brian Seed at the Massachusetts General Hospital, Harvard Medical School in Boston where he studied the molecular basis of lytic granule exocytosis. In 2003, Dr. Radoja joined the Center for Cancer and Immunology at Children’s National Medical Center. A molecular biologist and immunologist by training, Dr. Radoja has been focused on identifying the genes and mechanisms that regulate granule exocytosis mediated cytotoxicity, a major mechanism used by CTL to kill tumor and virally infected cells He has been involved in studies concerning determination of the genetic basis for hemophagocytic lymphohistiocytosis (HLH), a rare, fatal pediatric immune disorder. He has published more than 10 peer-reviewed articles.

Publications
View a partial list of publications for Sasa Radoja, PhD through the National Library of Medicine's PubMed online database.


Back to Top
 


   
Children's National Medical Center |
111 Michigan Avenue, NW Washington, DC 20010 | 202-476-5000 | © 2013 & Privacy Statement